Raetasha Dabney, M.D.
NPI 1124219449 · Hematology & Oncology Physician · Southlake, TX
Enrolled with Medicare as Practitioner - Hematology/Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1124219449
- Entity type
- Individual
- Primary specialty
- Hematology & Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- N3593 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
6,270 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Complete Blood Cell Count (red Cells, White Blood Cell, Platelets), Automated Test and Automated Differential White Blood Cell Count85025 | 835 | $8 |
| Blood Test, Comprehensive Group of Blood Chemicals80053 | 788 | $10 |
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 711 | $9 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 468 | $125 |
| Administration of Chemotherapy Into Vein, 1 Hour Or Less96413 | 261 | $126 |
| Infusion Into a Vein for Therapy, Prevention, Or Diagnosis, Additional Sequential Infusion, 1 Hour Or Less96367 | 237 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 23 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Anastrozole | 88 | 29 |
| Gabapentin | 62 | — |
| Lenalidomidebrand: Revlimid | 46 | — |
| Rivaroxabanbrand: Xarelto | 41 | — |
| Acyclovir | 41 | — |
| Ruxolitinib Phosphatebrand: Jakafi | 40 | — |
| Apixabanbrand: Eliquis | 32 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,344 across 56 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 3551 Roger Brooke DrFort Sam Houston, TX 78234-4504Phone: (210) 916-4808
- 7415 Las Colinas Blvd Ste 100Irving, TX 75063-7569Phone: (214) 379-2722Fax: (972) 869-3875
Registry dates
- Enumerated
- 2007-08-05
- Last updated
- 2020-04-19
- Certified
- 2020-04-19
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.